Kemper Corporation 5.875% Fixed-Rate Reset Junior Subordinated Debentures due 2062 (KMPB)

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

As a value investor, I look for margin of safety. This is a junior subordinated bond, so I must assess the issuer's ability to pay. Kemper's revenue has been stable around $4.8 billion in fiscal 2025, and it earned $143.3 million that year, up from a loss in fiscal 2023. That fits the turnaround label. However, the first half of 2026 shows a different picture: a small loss in Q1 and a massive $464.8 million loss in Q2. That single quarter wiped out more than three years of annual profits. Without balance sheet data, I can't compute interest coverage, but a loss of that magnitude raises serious questions about financial health. The bond yields about 5.9% at the current price of $24.82, which is not generous for a junior subordinated security with this risk profile. The price is near its 52-week high, suggesting the market is complacent. I would demand a higher yield to compensate for the subordination and the recent earnings volatility. The company's competitive moat is unclear from the figures; insurance is a commoditized business. Growth has been flat to slightly negative. While the annual turnaround is encouraging, the latest quarterly loss is a red flag. I would monitor the next few quarters closely to see if the loss is a one-time event or a new trend. For now, the risk/reward is not compelling.

In plain English: Kemper is an insurance company that issued this bond. The company has been profitable on an annual basis recently but reported a big loss in the second quarter of 2026. The bond trades near its $25 face value, so the price looks fair for the interest it pays, but the recent losses are a concern.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-16 close · note generated 2026-10-20 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer